Expression of podoplanin in different grades of oral squamous cell carcinoma
Open Access
- 1 January 2015
- journal article
- Published by Medknow in Annals of Medical and Health Sciences Research
- Vol. 5 (4) , 299-304
Abstract
The expression of podoplanin is up-regulated in a number of different human cancers, including squamous cell carcinoma of the oral cavity and its relationship with tumor invasion raises the possibility that podoplanin expression could be used as a biomarker for diagnosis and prognosis. The aim of the present study is to evaluate the expression of podoplanin in different grades of squamous cell carcinoma (SCC) and to correlate the expression of podoplanin with relevant clinical features such as age, sex, site and associated habits. Retrospective study was carried on formalin fixed, paraffin embedded blocks of oral SCC (OSCC) from the archives of Department of Oral and Maxillofacial Pathology, Vishnu Dental College, Bhimavaram. Thirty diagnosed cases were included, of which 10 were well-differentiated SCC (WDSCC) (n = 10), 10 moderately DSCC and 10 poorly DSCC. Demographics including age, sex, gender and associated habit history, were recorded. Immunohistochemical staining was done with podoplanin anti D2-40 antibody, for all the cases of OSCC and assessed qualitatively. The data obtained were tabulated and subjected to statistical analysis. In the present study, 27 cases of SCC showed podoplanin expression and remaining three cases showed no expression. The scoring criterion suggested by Yuan et al. was followed for semi-quantitative assessment. OSCC, seven cases presented weak expression (Immunoreactive score [IRS] 0-3), 15 presented moderate expression (IRS Score 4-7) and 5 presented high expression (IRS Score > 8). The assessment of podoplanin expression in the cytoplasm, the membrane and the cytoplasm and membrane (both) of tumor cells showed overall high positivity in the cytoplasmic followed by both and the membrane. Podoplanin could be a potent biomarker in assessing the cytoplasm/membrane staining of tumor cells. Furthermore, a high level of podoplanin expression is suggestive of high frequency of lymph node metastasis and immature status in the differentiation process of OSCC.Keywords
This publication has 18 references indexed in Scilit:
- Podoplanin in the development and progression of oral cavity cancer: a preliminary study.2012
- Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapyOral Oncology, 2011
- Genetics/epigenetics of oral premalignancy: current status and future research*Oral Diseases, 2011
- High-level expression of podoplanin in benign and malignant soft tissue tumors: Immunohistochemical and quantitative real-time RT-PCR analysisOncology Reports, 2011
- D2-40/podoplanin expression in the human placentaPlacenta, 2011
- Podoplanin expression in the development and progression of laryngeal squamous cell carcinomasMolecular Cancer, 2010
- Prognostic value of podoplanin expression in intratumoral stroma and neoplastic cells of uterine cervical carcinomasClinics, 2010
- The role of podoplanin in tumor progression and metastasis.2008
- How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis?World Journal of Surgical Oncology, 2007
- Tumor lymphangiogenesis in head and neck squamous cell carcinomaCancer, 2004